AzTrials
AzTrials

ArthroplastyJIICRBCSTKANCT04822259

Evaluate the Performance of JOURNEY II CR and JOURNEY II BCS in TKA Populations

A study testing JOURNEY II BCS Total Knee System and JOURNEY II CR Total Knee System in people with Arthroplasty and Replacement, run by Smith & Nephew, Inc. at 5 sites in 3 countries.

Withdrawn

Withdrawn. The study stopped before anyone enrolled.

Official record
Search all trials

Trial summary

Background: The JOURNEY II BCS Total Knee System (JOURNEY II Bi-cruciate Stabilized Total Knee System) consists of femoral component made from oxidized zirconium (OXINIUM) The JOURNEY II CR Total Knee System (JOURNEY II Cruciate Retaining Total Knee System ) consists of femoral component made from oxidized zirconium… Read more about this study

Who is it for?
Ages 18 to 80 years
Conditions the study is for
Arthroplasty, Replacement, Knee
What is being tested?
JOURNEY II BCS Total Knee System and JOURNEY II CR Total Knee System
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
0 participants
Where
5 sitesin 3 countries
Study dates
28 Aug 2022to 31 Dec 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Subjects with degenerative osteoarthritis.
  • Subject is planning to have bilateral Total Knee Arthroplasty (TKA) using JOURNEY II BCS \& CR or have unilateral TKA using JOURNEY II BCS or JOURNEY II CR.*
  • Subject is able and willing to provide voluntary consent to study participation.
  • Subject is 18-80 years old (inclusive).
  • [ Bilateral cases can be simultaneous bilateral or staged bilateral (which an interval of 6-8 weeks apart between both knees)]

Who cannot join

  • Subjects with rheumatoid arthritis/inflammatory arthritis, posttraumatic arthritis.
  • Previous surgeries including High Tibial Osteotomy (HTO), Unicondylar Knee Arthroplasty (UKA) or Total Knee Arthroplasty (TKA) on the subject knee.
  • Subject is pregnant or breast feeding or those at a child-bearing age planning to become pregnant during the follow up.
  • Subject does not meet the indication or is contraindicated for JOURNEY II BCS \& JOURNEY II CR's Instructions For Use (IFU).

Trial locations and contacts

5 sites in 3 countries.

5 sites in 3 countries

China2 sites
  • Peking University Third Hospital

    Beijing, 100083

  • Prince of Wales Hospital

    Hong Kong

Other trials in China

India2 sites
  • Aster RV Hospital, Bangalore

    Bengaluru, Karnataka, 560078

  • Noble Hospital & Ruby Hall Clinic

    Pune, Maharashtra, 411001

Other trials in India

Singapore1 site
  • Singapore General Hospital

    Singapore, 169608

Other trials in Singapore

About this study

Official title: A Prospective Multi-Centre Study in Patients Undergoing Total Knee Replacement With JOURNEY II BCS and CR Total Knee System

Background:

The JOURNEY II BCS Total Knee System (JOURNEY II Bi-cruciate Stabilized Total Knee System) consists of femoral component made from oxidized zirconium (OXINIUM)

Read more

The JOURNEY II CR Total Knee System (JOURNEY II Cruciate Retaining Total Knee System ) consists of femoral component made from oxidized zirconium (OXINIUM)

Purpose:

Post-market evidence generation for JOURNEY II BCS and JOURNEY II CR Total Knee System

Objectives:

  1. Evaluate the performance of JOURNEY II TKA in Asia-Pacific (APAC) patient populations
  2. Establish the equivalent performance between JOURNEY II BCS and JOURNEY II CR to support adoption of JOURNEY II CR

Research participants / locations:

A total of at least 176 knees' information will be collected in up to 10 sites. There will be at least eighty-eight (88) knees for JOURNEY II CR TKA group and at least 88 knees for JOURNEY II BCS TKA group.

Being tested
JOURNEY II BCS Total Knee System, JOURNEY II CR Total Knee System
Keywords
Osteoarthritis, Total knee arthroplasty (TKA), Cruciate Retaining (CR), Bi-cruciate Stabilized (BCS)
Medical subject headings
Osteoarthritis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • JOURNEY II BCS Total Knee SystemDevice

    Undergoing Total Knee Replacement(resurfaced patella) with JOURNEY II BCS Total Knee System

  • JOURNEY II CR Total Knee SystemDevice

    Undergoing Total Knee Replacement(resurfaced patella) with JOURNEY II CR Total Knee System

Study groups in NCT04822259
Study groupRoleWhat they receive
JOURNEY II BCS TKAExperimentalUndergoing Total Knee Replacement(resurfaced patella) with JOURNEY II BCS Total Knee System
Receives: Device: JOURNEY II BCS Total Knee System
JOURNEY II CR TKAExperimentalUndergoing Total Knee Replacement(resurfaced patella) with JOURNEY II CR Total Knee System
Receives: Device: JOURNEY II CR Total Knee System

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Oxford Knee Score (OKS) at 2 years

    The Oxford Knee Score (OKS) is a Patient Reported Outcome (PRO) questionnaire that was developed to specifically assess the patient's perspective of outcome following Total Knee Arthroplasty (TKA). The OKS is a patient self-completion PRO containing 12 equally weighted questions on activities of daily living. The OKS has been developed and validated specifically to assess perceived function and pain answered on a Likert scale after TKA. Responses to each question ranges from 0-4 with a range of a possible overall score from 0-48. A score of 0 is the worst possible outcome while a score of 48 is the best possible outcome.

    Measured: 2 years

Secondary outcomes (8)
  1. Forgotten Joint Score (FJS)

    The FJS comprises measures for the assessment of joint-specific patient reported outcomes. This questionnaire focuses on the study subject's awareness of the partially or fully replaced knee joint in everyday life. Joint awareness can be simply defined as any unintended perception of a joint. Subjects are asked to rate their awareness of their knee arthroplasty in 12 questions with a five-point Likert response format: "Never", "almost never", "seldom", "sometimes" and "mostly". The item scores are summed and linearly transformed in a 0 to 100 scale with a high value reflecting the ability of the subject to forget about the replaced knee joint during the activities of daily living.

    Measured: 6 months, 1 year , 2 years, 3 years

  2. Oxford Knee Score (OKS)

    The Oxford Knee Score (OKS) is a Patient Reported Outcome (PRO) questionnaire that was developed to specifically assess the patient's perspective of outcome following Total Knee Arthroplasty (TKA). The OKS is a patient self-completion PRO containing 12 equally weighted questions on activities of daily living. The OKS has been developed and validated specifically to assess perceived function and pain answered on a Likert scale after TKA. Responses to each question ranges from 0-4 with a range of a possible overall score from 0-48. A score of 0 is the worst possible outcome while a score of 48 is the best possible outcome.

    Measured: Pre-Operative, 6 months, 1 year, 3 years

  3. Knee Society Score (KSS)

    The KSS is a validated tool that combines an objective physician-derived component with a subjective subject-derived component and consists of 4 separate sub-scales:

    1. An "Objective" Knee Score (seven items: 100 points)
    2. A Patient Satisfaction Score (five items: 40 points)
    3. A Patient Expectation Score (three items: 15 points)
    4. A Functional Knee Score (19 items: 100 points)

    The Functional Knee Score is derived from assessments of walking and standing, standard activities, advanced activities, and discretionary activities. A higher number is a better outcome.

    Measured: Pre-Operative, 6 months, 1 year, 2 years, 3 years

  4. Patient Expectation

    The patient expectation will be one single question which have 9 options to choose.

    Patients need to choose at which level of activity he/she expect to recover after surgery.

    The option will be from the most intensive activity to least intensive activity.

    Measured: Pre-Operative

  5. Patient Satisfaction

    The patient satisfaction will be a corresponding question based on the expectation. It's a five -Likert options (from very satisfied to very dissatisfied) for patients to choose how satisfied he/she is with the surgery to meet the expectation.

    Measured: 6 months, 1 year, 2 years, 3 years

  6. Radiographic Assessment

    Standard radiographic evaluation on antero-posterior (A/P) and lateral views shall be performed at the determined time point before and after surgery in order to identify any radiographic observations such as radiolucent lines around the implant components. The presence of radiolucent lines, osteolysis \& implant migration shall be recorded in the electronic Case Report Form (eCRF).

    Measured: Pre-Operative, 6 months, 1 year, 2 years, 3 years

  7. Timed Up and Go Test (TUG)

    The Timed Up and Go Test assesses mobility, balance, walking ability, and fall risk in adults by measuring time, in seconds, that it takes the individual to stand from a chair, walk a distance of 10 feet (around 3 meters), walk back to the chair, and sit down. The subject will perform the test in their everyday footwear with their walking aid (cane, walker), if applicable [39]. The site will follow the guidelines provided by the Centers for Disease Control and Prevention recording the results on the form provided by the Sponsor

    Measured: Pre-Operative, Immediate Post -op to 6 weeks, 6 months, 1 year

  8. Star Excursion Balance Test (SEBT)

    The SEBT has been introduced as a simple, reliable, and cost-effective alternative for instrumental devices to assess semi-dynamic balance. The SEBT is a functional test that incorporates a single-leg stance on 1 leg while trying to reach as far as possible with the opposite leg. Each patient performed 3 reaches (trials) in each of the 8 directions. The average of the maximum reach distance in each of the 8 directions was considered for analysis.

    Measured: Pre-Operative, Immediate Post -op to 6 weeks, 6 months, 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Mar 2021
  2. Study start28 Aug 2022 (estimated)
  3. Primary completion31 Dec 2022 (estimated)
  4. Study completion31 Dec 2025 (estimated)

Why it stopped: Study design is not reasonable and sponsor decided to terminate the study. No patient enrolled by now

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
0 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04822259
Sponsor's protocol ID
Journey II CR + BCS.2020.12
Acronym
JIICRBCSTKA
Status last verified
Jun 2022
First submitted
26 Mar 2021
Last updated
7 Jun 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing JOURNEY II BCS Total Knee System and JOURNEY II CR Total Knee System in people with Arthroplasty and Replacement, run by Smith & Nephew, Inc. at 5 sites in 3 countries.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: withdrawn, as of the sponsor's last update on 7 Jun 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 5 sites in China, India, Singapore. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was withdrawn before enrolling participants, so there are no results.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Oxford Knee Score (OKS) at 2 years (time frame: 2 years). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Jun 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in